Cargando…

No relationship between thymidine phosphorylase (TP, PD-ECGF) expression and hypoxia in carcinoma of the cervix

The expression of hypoxia-regulated genes promotes an aggressive tumour phenotype and is associated with an adverse cancer treatment outcome. Thymidine phosphorylase (TP) levels increase under hypoxia, but the protein has not been studied in association with hypoxia in human tumours. An investigatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kabuubi, P, Loncaster, J A, Davidson, S E, Hunter, R D, Kobylecki, C, Stratford, I J, West, C M L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361082/ https://www.ncbi.nlm.nih.gov/pubmed/16317434 http://dx.doi.org/10.1038/sj.bjc.6602882

Ejemplares similares

Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors
por: Bijnsdorp, I V, et al.
Publicado: (2011)

Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma
por: Lee, S, et al.
Publicado: (2010)

Lacking hypoxia-mediated downregulation of E-cadherin in cancers of the uterine cervix
por: Mayer, A, et al.
Publicado: (2013)

Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer
por: Irlam-Jones, J J, et al.
Publicado: (2016)

Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.
por: Griffiths, L., et al.
Publicado: (1997)

Human papillomavirus 16 infection in adenocarcinoma of the cervix
por: Chew, G K, et al.
Publicado: (2005)

Human papillomaviral load changes in low-grade squamous intraepithelial lesions of the uterine cervix
por: Ho, C-M, et al.
Publicado: (2006)

Parallel cyclin E and cyclin A expression in neoplastic lesions of the uterine cervix
por: Erlandsson, F, et al.
Publicado: (2006)

Unique volatolomic signatures of TP53 and KRAS in lung cells
por: Davies, M P A, et al.
Publicado: (2014)

TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy
por: Oden-Gangloff, A, et al.
Publicado: (2009)

Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia–dysplasia–adenocarcinoma sequence
por: Griffiths, E A, et al.
Publicado: (2007)

Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype
por: Barathova, M, et al.
Publicado: (2008)

Prognostic value of increase in transcript levels of Tp73 ΔEx2-3 isoforms in low-grade glioma patients
por: Wager, M, et al.
Publicado: (2006)

‘Desperate house genes’: the dramatic example of hypoxia
por: Caradec, J, et al.
Publicado: (2010)

Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis
por: Sivridis, E, et al.
Publicado: (2002)

Hypoxia-associated markers in gastric carcinogenesis and HIF-2α in gastric and gastro-oesophageal cancer prognosis
por: Griffiths, E A, et al.
Publicado: (2008)

The cytosol activity of thymidine phosphorylase in endometrial cancer
por: Miszczak-Zaborska, Elżbieta, et al.
Publicado: (2008)

Expression of Thymidine Phosphorylase in Human Gastric Carcinoma
por: Takebayashi, Yuji, et al.
Publicado: (1996)

Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis
por: Blick, C, et al.
Publicado: (2015)

Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix
por: Loncaster, J A, et al.
Publicado: (2000)

Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis
por: Rasheed, S, et al.
Publicado: (2009)

EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer
por: Youssef, M M S, et al.
Publicado: (2006)

Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase
por: Di Gennaro, E, et al.
Publicado: (2010)

The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer
por: Otto, N, et al.
Publicado: (2012)

PICT1 regulates TP53 via RPL11 and is involved in gastric cancer progression
por: Uchi, R, et al.
Publicado: (2013)

Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway
por: Joshi, H, et al.
Publicado: (2012)

Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis
por: Marchetti, S, et al.
Publicado: (2001)

Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value
por: Lomnytska, M I, et al.
Publicado: (2011)

HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
por: Meulendijks, D, et al.
Publicado: (2015)

A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis
por: Nam, S Y, et al.
Publicado: (2011)

Hypoxia-inducible factor-1α expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas
por: Griffiths, E A, et al.
Publicado: (2007)

Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer
por: Jubb, A M, et al.
Publicado: (2009)

Expression of the thymidine phosphorylase gene in epithelial ovarian cancer
por: Hata, K, et al.
Publicado: (1999)

Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine cervical cancers
por: Fujimoto, J, et al.
Publicado: (1999)

PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer
por: Wigfield, S M, et al.
Publicado: (2008)

Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer
por: Shaw, R J, et al.
Publicado: (2009)

Structures of native human thymidine phosphorylase and in complex with 5-iodouracil
por: Mitsiki, Eirini, et al.
Publicado: (2009)

Comparison of hypoxia transcriptome in vitro with in vivo gene expression in human bladder cancer
por: Ord, J J, et al.
Publicado: (2005)

miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis
por: McCormick, R I, et al.
Publicado: (2013)

Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia
por: Maftouh, M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3820c6hnqbhliknj7lrdlqs7rn